Lindsey Anderson
Psychiatric/Mental Health · Cleburne, TXNPI 1154905669
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,200 of the $12,699 with a category attached, or 64.6%. AbbVie accounts for 77.3% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $5,937, more than ten times the $526 reported in 2021. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 272 payments — averaging $46.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$10K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$596
- Neurocrine Biosciences, Inc.$497
- Alkermes, Inc.$465
- Teva Pharmaceuticals USA, Inc.$281
- Johnson & Johnson$267
- plus $782 from 6 others
What the payments were for
- Speaking & faculty fees$8,20065%
- Travel & lodging$6485%
- Food & beverage$3,85130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 84 | $9,812 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 52 | $596 |
| Neurocrine Biosciences, Inc. | 15 | $497 |
| Alkermes, Inc. | 31 | $465 |
| Teva Pharmaceuticals USA, Inc. | 11 | $281 |
| Johnson & Johnson(2 entities) | 16 | $267 |
| Otsuka America Pharmaceutical, Inc. | 18 | $234 |
| Sunovion Pharmaceuticals Inc. | 21 | $208 |
| Lundbeck LLC | 17 | $199 |
| Indivior Inc. | 4 | $67 |
| Millicent US Inc | 2 | $41 |
| Axsome Therapeutics, Inc. | 1 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,699 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clozapine | 14 | $1,383 |
| Hydroxyzine Hcl | 18 | $618 |
| Gabapentin | 22 | $587 |
| Aripiprazole | 28 | $574 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 19 | $481 |
| Buspirone Hcl | 29 | $449 |
| Quetiapine Fumarate | 24 | $380 |
| Trazodone Hcl | 16 | $368 |
| Prazosin Hcl | 15 | $350 |
| Duloxetine Hcl | 13 | $261 |
| Risperidone | 14 | $212 |
| Benztropine Mesylate | 14 | $206 |
| Bupropion XlBupropion Hcl | 17 | $162 |
| Sertraline Hcl | 15 | $150 |
| Topiramate | 20 | $143 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Cleburne
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
- Marguerite AddisonWaco$118K
- Komi Kokou-AbiRound Rock$88K
- Jaime Nelson DensonAustin$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.